BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28541590)

  • 1. Renal artery sympathetic nerve radiofrequency denervation.
    Bartuś K; Sadowski J; Kapelak B; Litwinowicz R; Podolec J; Bartuś M; Dziewierz A; Bartuś S; Zajdel W; Lakkireddy D
    Kardiol Pol; 2017; 75(9):899-906. PubMed ID: 28541590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denervation of nerve terminals in renal arteries: one-year follow-up of interventional treatment of arterial hypertension.
    Bartuś K; Sadowski J; Kapelak B; Litwinowicz R; Zajdel W; Godlewski J; Bartuś M; Zmudka K; Chrapusta A; Konstanty-Kalandyk J; Węgrzyn P; Sobotka PA
    Kardiol Pol; 2014; 72(5):425-31. PubMed ID: 24408071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denervation (ablation) of nerve terminalis in renal arteries: early results of interventional treatment of arterial hypertension in Poland.
    Bartuś K; Sadowski J; Kapelak B; Zajdel W; Godlewski J; Bartuś S; Bochenek M; Bartuś M; Żmudka K; Sobotka PA
    Kardiol Pol; 2013; 71(2):152-8. PubMed ID: 23575708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K; Rommel KP; Lapusca R; Blazek S; Besler C; Hartung P; von Roeder M; Kresoja KP; Desch S; Thiele H; Lurz P
    Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure reduction in patients with accessory renal arteries and bilateral single renal arteries after catheter-based renal denervation: a prospective study with 3-year follow-up.
    Bartus K; Podolec J; Sadowski J; Litwinowicz R; Zajdel W; Bartus M; Konstanty-Kalandyk J; Dziewierz A; Trąbka R; Bartus S; Chrapusta A; Kapelak B
    Pol Arch Intern Med; 2017 Jun; 127(6):423-428. PubMed ID: 28436415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
    Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
    Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.
    Witkowski A; Prejbisz A; Florczak E; Kądziela J; Śliwiński P; Bieleń P; Michałowska I; Kabat M; Warchoł E; Januszewicz M; Narkiewicz K; Somers VK; Sobotka PA; Januszewicz A
    Hypertension; 2011 Oct; 58(4):559-65. PubMed ID: 21844482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension.
    Ahmed H; Neuzil P; Skoda J; Petru J; Sediva L; Schejbalova M; Reddy VY
    JACC Cardiovasc Interv; 2012 Jul; 5(7):758-65. PubMed ID: 22814781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of two different renal denervation strategies on blood pressure in resistant hypertension: Comparison of full-length versus proximal renal artery ablation.
    Chen W; Ling Z; Du H; Song W; Xu Y; Liu Z; Su L; Xiao P; Yuan Y; Lu J; Zhang J; Li Z; Shao J; Zhong B; Zhou B; Woo K; Yin Y
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):786-795. PubMed ID: 27219520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse Wave Velocity Predicts Response to Renal Denervation in Isolated Systolic Hypertension.
    Fengler K; Rommel KP; Hoellriegel R; Blazek S; Besler C; Desch S; Schuler G; Linke A; Lurz P
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
    Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
    Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 Investigators
    Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry).
    Kądziela J; Prejbisz A; Kostka-Jeziorny K; Dudek D; Narkiewicz K; Sadowski J; Lekston A; Gziut A; Więcek A; Buszman P; Kleinrok A; Kochman J; Czarnecka D; Januszewicz A; Witkowski A
    Kardiol Pol; 2016; 74(9):961-8. PubMed ID: 27160171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the presence of accessory renal arteries affect the efficacy of renal denervation?
    Id D; Kaltenbach B; Bertog SC; Hornung M; Hofmann I; Vaskelyte L; Sievert H
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1085-91. PubMed ID: 24156968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.